Ignite Creation Date:
2025-12-24 @ 10:50 PM
Ignite Modification Date:
2026-01-04 @ 5:58 AM
Study NCT ID:
NCT00127569
Status:
TERMINATED
Last Update Posted:
2007-01-12
First Post:
2005-08-04
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Rituximab in the Treatment of HIV Associated Multicentric Castleman Disease Dependent on Chemotherapy
Sponsor:
French National Agency for Research on AIDS and Viral Hepatitis
Organization:
Organization Data
Organization:
Class:
OTHER_GOV
Study ID:
ANRS 117 CastlemaB
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER_GOV
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |